PRKACA anticorps (AA 563-672)
PRKACA
Reactivité: Humain
WB, ELISA, IHC, IF
Hôte: Souris
Monoclonal
2F11
unconjugated
N° du produit ABIN2340986
-
-
Antigène
Voir toutes PRKACA Anticorps
-
PRKACA
(Protein Kinase A, alpha (PRKACA))
-
Épitope
-
AA 563-672
-
Reactivité
-
Humain
-
Hôte
-
Souris
-
Clonalité
-
Monoclonal
-
Conjugué
-
Cet anticorp PRKACA est non-conjugé
-
Application
-
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
-
Réactivité croisée
-
Humain
-
Réactivité croisée (Details)
-
Calculated cross reactivity: Hu
-
Attributs du produit
-
PRKACA (Protein Kinase C alpha Type, AAG6, PKC-A, PKCA, PKC-alpha, MGC102831, MGC48865)
-
Purification
-
Purified by Protein A affinity chromatography.
-
Immunogène
-
Partial recombinant corresponding to aa563-672 from human PRKCA (NP_002728) with GST tag. MW of the GST tag alone is 26kD.
-
Clone
-
2F11
-
Isotype
-
IgG1 kappa
-
Top Product
-
Discover our top product PRKACA Anticorps primaire
-
-
-
Indications d'application
-
Optimal working conditions should be determined by the investigator.
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Buffer
-
Supplied as a liquid in PBS, pH 7.2.
-
Stock
-
-20 °C
-
Stockage commentaire
-
-20°C
-
-
Antigène
-
PRKACA
(Protein Kinase A, alpha (PRKACA))
-
Autre désignation
-
PRKACA (PRKACA Produits)
-
Synonymes
-
anticorps PKACA, anticorps Calpha, anticorps Cs-PKA, anticorps PKCA1, anticorps PKA, anticorps PKCD, anticorps Pkaca, anticorps zgc:158799, anticorps protein kinase cAMP-activated catalytic subunit alpha, anticorps protein kinase, cAMP dependent, catalytic, alpha, anticorps cAMP-dependent protein kinase catalytic subunit, anticorps protein kinase, cAMP-dependent, catalytic, alpha, genome duplicate a, anticorps PRKACA, anticorps Prkaca, anticorps kin-1, anticorps prkacaa
-
NCBI Accession
-
NM_002737, NP_002728
-
Pathways
-
Signalisation NF-kappaB, Signalisation Hedgehog, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, Carbohydrate Homeostasis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, Lipid Metabolism, SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2
-